Ambeed.cn

首页 / / / / (S)-(+)-Rolipram/(S)-(+)-咯利普兰

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 {[allProObj[0].p_purity_real_show]}

货号:A107169 同义名: S-(+)-Rolipram; (+)-Rolipram

(S)-(+)-Rolipram is a PDE4-inhibitor and an anti-inflammatory agent, less potent than its R-enantiomer.

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 化学结构 CAS号:85416-73-5
(S)-(+)-Rolipram/(S)-(+)-咯利普兰 化学结构
CAS号:85416-73-5
(S)-(+)-Rolipram/(S)-(+)-咯利普兰 3D分子结构
CAS号:85416-73-5
(S)-(+)-Rolipram/(S)-(+)-咯利普兰 化学结构 CAS号:85416-73-5
(S)-(+)-Rolipram/(S)-(+)-咯利普兰 3D分子结构 CAS号:85416-73-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 纯度/质量文件 产品仅供科研

货号:A107169 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 PDE PDE1 PDE10A PDE2 PDE3 PDE4 PDE5 PDE6 其他靶点 纯度
Doxofylline 99+%
Deltarasin +++

PDEδ , Kd: 38 nM

95%
7-(2,3-Dihydroxypropyl)theophylline 98%
Aminophylline +

PDE, IC50: 0.12 mM

98+%
Anagrelide HCl 99%+
Irsogladine AChR,mAChR 99%
PF-8380 +++

Autotaxin, IC50: 2.8 nM

99%+
Dipyridamole 98%
Balipodect ++++

PDE10A, IC50: 0.3 nM

99%+
Luteolin +

PDE1, Ki: 15.0 μM

++

PDE2, Ki: 6.4 μM

+

PDE3, Ki: 13.9 μM

+

PDE4, Ki: 11.1 μM

+

PDE5, Ki: 9.5 μM

98%
Milrinone ++

PDE2, IC50: 5.2 μM

++

PDE3, IC50: 2.1 μM

ATPase 99%
Pimobendan ++

PDE3, IC50: 0.32 μM

98%
Cilostazol ++

PDE3, IC50: 0.2 μM

98%
Fenspiride HCl +

PDE3, pIC50: 3.44

+

PDE4, pIC50: 4.16

99% (HPLC)
(S)-(+)-Rolipram ++

PDE4, IC50: 0.75 μM

99% (HPLC)
Apremilast +++

PDE4, IC50: 74 nM

98%
GSK256066 ++++

PDE4B, IC50: 3.2 pM

98+%
Roflumilast ++++

PDE4A4, IC50: 4.3 nM

PDE4A1, IC50: 0.7 nM

99%
Rolipram +++

PDE4B, IC50: 130 nM

99%+
Cilomilast +++

HPDE4, IC50: 120 nM

LPDE4, IC50: 100 nM

99%
Avanafil ++++

PDE5, IC50: 1 nM

98%
Vardenafil HCl Trihydrate ++++

PDE5, IC50: 0.7 nM

98%
Tadalafil ++++

PDE5, IC50: 1.8 nM

98%
Icariin ++

PDE5, IC50: 0.432 μM

98%
Sildenafil +++

PDE6, IC50: 33 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 生物活性

靶点
  • PDE4

    PDE4, IC50:0.75 μM

描述 (S)-(+)-Rolipram, known as (+)-Rolipram, is a selective inhibitor of cyclic AMP (cAMP)-specific phosphodiesterase 4 (PDE4) with an IC50 of 1100 nM. It is effective in suppressing tumor necrosis factor-alpha (TNFα) production in human mononuclear cells[1].[2].[3].
体内研究

Moreover, (+)-Rolipram (0.025-6.25 mg/kg; a single i.p. injection) reduces locomotor activity and induces head twitches in rats in a dose-dependent manner[2].

In further studies, (+)-Rolipram (0.06-25 mg/kg; a single i.p. injection) leads to a dose-related decrease in the rectal temperature of rats[2].

体外研究

In laboratory settings, (+)-Rolipram (0.015-1000 μM; 20 h) has shown a dose-dependent ability to inhibit LPS-induced TNF production in human mononuclear cells, with an IC50 value of 550 nM[1].

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 细胞实验

Cell Line
Concentration Treated Time Description References
mouse primordial germ cell-like cells (PGCLCs) 10 μM 7 days Screening for chemicals that promote PGCLC proliferation, (S)-(+)-Rolipram was found to significantly promote PGCLC proliferation EMBO J. 2017 Jul 3;36(13):1888-1907
hippocampal slices 0.1µM 60 min To investigate the rescuing effect of rolipram on LTP deficits caused by sleep deprivation, results showed that rolipram rescued the LTP deficits caused by sleep deprivation Nature. 2009 Oct 22;461(7267):1122-5
Adult feline left ventricular myocytes 1 μM To evaluate the effect of rolipram on ISO-mediated cAMP generation, results showed that rolipram significantly enhanced ISO-induced cAMP generation. Circulation. 2014 Nov 11;130(20):1800-11
hippocampal slices 1 μM 20 min To test the effect of rolipram on LTP deficits in hippocampal slices from APP/PS1 mice. Results showed that rolipram significantly ameliorated LTP deficits in APP/PS1 hippocampal slices, bringing LTP levels close to those of wild-type mice. J Clin Invest. 2004 Dec;114(11):1624-34
CHO cells 0.1, 0.25, 0.5, 1.0, and 2.0 μM 18 h Rolipram overcame inhibition by MAG and myelin in a dose-dependent manner, completely blocking inhibition by MAG at 0.5 μM. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8786-90.
hippocampal slices 0.03 μM, 0.3 μM, 3.0 μM 45 min Low concentrations of rolipram had no significant effect on basal cAMP levels, but significantly amplified the cAMP response to forskolin stimulation. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Sleep deprivation model Intraperitoneal injection 1 mg/kg Injected immediately and 2.5 hours after training To investigate the rescuing effect of rolipram on memory deficits caused by sleep deprivation, results showed that rolipram rescued the memory deficits caused by sleep deprivation Nature. 2009 Oct 22;461(7267):1122-5
Mice APP/PS1 double-transgenic mice Subcutaneous injection 0.03 mg/kg Acute administration: single dose 30 minutes before testing; Long-term administration: daily dose of 0.03 mg/kg for 3 weeks, followed by 6-8 weeks of withdrawal before testing. To test the acute and long-term effects of rolipram on cognitive and synaptic functions in APP/PS1 mice. Acute administration significantly improved contextual fear conditioning deficits in APP/PS1 mice but had no significant effect on spatial working memory. Long-term administration significantly improved synaptic function (BST and LTP) and multiple cognitive functions (including associative learning, working memory, and reference memory) in APP/PS1 mice, with effects lasting at least 2 months after treatment cessation. J Clin Invest. 2004 Dec;114(11):1624-34
Mice C57/Bl6 mice Subcutaneous injection 0.1 μmol/kg, 3.0 μmol/kg 30 min before training Low-dose rolipram significantly enhanced long-term memory (24-hr freezing), while high doses caused behavioral toxicity. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5
Sprague-Dawley rats Acute and subacute inflammation models Intraperitoneal injection 8 mg/kg Single dose, observed for 60 min or 4 h Rolipram significantly inhibited PAF or LPS-induced leukocyte rolling, adhesion, and emigration, and downregulated P- and E-selectin expression, but had no effect on ICAM-1 and VCAM-1 expression. Br J Pharmacol. 2002 Apr;135(8):1872-81

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 参考文献

[1]Semmler J, et, al. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int J Immunopharmacol. 1993 Apr;15(3):409-13.

[2]Wachtel H. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo. J Pharm Pharmacol. 1983 Jul;35(7):440-4.

[3]Ortmann R, et, al. Rolipram forms a potent discriminative stimulus in drug discrimination experiments in rats. Psychopharmacology (Berl). 1986;89(3):273-7.

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.63mL

0.73mL

0.36mL

18.16mL

3.63mL

1.82mL

36.32mL

7.26mL

3.63mL

(S)-(+)-Rolipram/(S)-(+)-咯利普兰 技术信息

CAS号85416-73-5
分子式C16H21NO3
分子量 275.34
SMILES Code O=C1NC[C@@H](C1)C2=CC=C(C(OC3CCCC3)=C2)OC
MDL No. MFCD03093861
别名 S-(+)-Rolipram; (+)-Rolipram; (S)-Rolipram
运输蓝冰
InChI Key HJORMJIFDVBMOB-GFCCVEGCSA-N
Pubchem ID 158758
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

溶解方案

DMSO: 105 mg/mL(381.34 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。